Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

NCT00195299 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: Temsirolimus

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer